Trabectedin

Trabectedin is a tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer. It has a role as an alkylating agent, an antineoplastic agent, an angiogenesis modulating agent, an anti-inflammatory agent and a marine metabolite. It is an organic sulfide, an isoquinoline alkaloid, a lactone, a polyphenol, an azaspiro compound, a bridged compound, an oxaspiro compound, an organic heteropolycyclic compound, an acetate ester, a tertiary amino compound and a hemiaminal.

Disclaimer: The information above is provided for general reference purposes only. Applications, dosage, handling procedures and suitability for any specific use must be determined solely by the user based on their own assessment. This information does not constitute a recommendation or endorsement for any particular application and should not be used as the basis for product selection.